Search by Drug Name or NDC
NDC 68118-0100-01 Zanosar 1 g/10mL Details
Zanosar 1 g/10mL
Zanosar is a INTRAVENOUS POWDER, FOR SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by ESTEVE PHARMACEUTICALS, S.A.. The primary component is STREPTOZOCIN.
MedlinePlus Drug Summary
Streptozocin is used to treat cancer of the pancreas that has gotten worse or spread to other parts of the body. Streptozocin is in a class of medications called alkylating agents. It works by slowing or stopping the growth of cancer cells in your body.
Related Packages: 68118-0100-01Last Updated: 04/28/2024
MedLinePlus Full Drug Details: Streptozocin
Product Information
| NDC | 68118-0100 |
|---|---|
| Product ID | 68118-100_f87746a1-78c9-df32-e053-6294a90a80da |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | Zanosar |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Streptozocin |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | POWDER, FOR SOLUTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 1 |
| Active Ingredient Units | g/10mL |
| Substance Name | STREPTOZOCIN |
| Labeler Name | ESTEVE PHARMACEUTICALS, S.A. |
| Pharmaceutical Class | Alkylating Activity [MoA], Alkylating Drug [EPC] |
| DEA Schedule | n/a |
| Marketing Category | UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE |
| Application Number | n/a |
| Listing Certified Through | 2024-12-31 |
Package
NDC 68118-0100-01 (68118010001)
| NDC Package Code | 68118-100-01 |
|---|---|
| Billing NDC | 68118010001 |
| Package | 1 VIAL, GLASS in 1 CARTON (68118-100-01) / 10 mL in 1 VIAL, GLASS |
| Marketing Start Date | 2023-02-01 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |